ArticleEBioMedicine2021

Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial.

Thomas R Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.